Wang, L., Wu, J., Shao, P., Bao, W., Mao, L., Pan, Z., . . . Fan, G. (2025, June). An Advanced IVB Lung Adenocarcinoma Patient With KRAS Mutations, Benefited From Camrelizumab Combined With Anti‐Angiogenic Agents for Therapy: A Case Report. Cancer Reports.
Chicago Style (17th ed.) CitationWang, Li, et al. "An Advanced IVB Lung Adenocarcinoma Patient With KRAS Mutations, Benefited From Camrelizumab Combined With Anti‐Angiogenic Agents for Therapy: A Case Report." Cancer Reports Jun. 2025.
MLA (9th ed.) CitationWang, Li, et al. "An Advanced IVB Lung Adenocarcinoma Patient With KRAS Mutations, Benefited From Camrelizumab Combined With Anti‐Angiogenic Agents for Therapy: A Case Report." Cancer Reports, Jun. 2025.
Warning: These citations may not always be 100% accurate.